Related Experiment Video

Updated: Jun 26, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.2K

Saudi expert consensus on acquired hemophilia A diagnosis and management

Abdulkareem M Almomen1, Hazza A Alzahrani2, Hussein H AlSaeed3

  • 1Department of Pathology, College of Medicine, King Saud University, Riyadh, KSA.

Journal of Taibah University Medical Sciences
|May 13, 2024
PubMed

Insights

Acquired hemophilia A, a rare bleeding disorder, requires prompt diagnosis and management to prevent severe complications. This consensus provides essential guidelines for practitioners in the Kingdom of Saudi Arabia (KSA) to improve patient outcomes.

Area of Science:

  • Hematology
  • Internal Medicine

Background:

  • Acquired hemophilia A is a rare autoimmune disorder affecting approximately 1 in 1 million individuals.
  • Delayed diagnosis is common due to lack of physician expertise, leading to prolonged underdiagnosis and potential life-threatening bleeding events.

Purpose of the Study:

  • To establish comprehensive diagnostic and management guidelines for acquired hemophilia A.
  • To equip all healthcare practitioners in the Kingdom of Saudi Arabia (KSA) with the necessary knowledge to manage this rare condition.

Main Methods:

  • Development of a consensus statement by a panel of hematology specialists.
  • Utilized an explicit systematic process to identify areas of consensus and divergence.

Main Results:

  • The consensus provides a practical guide for diagnosing acquired hemophilia A, detailing clinical presentations and bleeding characteristics.
  • It outlines management strategies, including diagnosis and treatment modalities, specifically for the KSA context.

Conclusions:

  • This consensus statement aims to bridge the knowledge gap among physicians, particularly non-specialists, in diagnosing and managing acquired hemophilia A.
  • It empowers practitioners in the KSA with expert-driven recommendations to ensure timely and effective care for patients with acquired hemophilia A.
Abstract

Keywords:
AcquiredConsensusExpertHemophiliaSaudi

More Related Videos

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

18.3K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
862
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.4K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
545
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.3K